Camidanlumab tesirine Uses, Dosage, Side Effects and more
Camidanlumab tesirine is under investigation in clinical trial NCT04639024 (ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN).
| Trade Name | Camidanlumab tesirine |
| Generic | Camidanlumab tesirine |
| Camidanlumab tesirine Other Names | Camidanlumab tesirine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
